Drugmaker Dr Reddys Laboratories is in discussions with the Russian Direct Investment Fund (RDIF) for acquiring rights of Covid-19 vaccine Sputnik V for more countries. So this is the overall view that we have at this stage of Sputnik," Chief Executive Officer of Dr Reddys, Erez Israeli said in a recent Earnings Conference Call, as reported by news agency PTI. Dr Reddy's and Apollo Hospital recently announced that they have kicked off the first phase of vaccinations with Sputnik V in Hyderabad and Visakhapatnam in India. Dr Reddy’s Laboratories plans to supply Sputnik V to the Indian government only when local production begins around July. RDIF has tied up with six Indian drug makers to manufacture Sputnik V and their supplies are expected to roll out by August or September.

Source: Mint May 19, 2021 08:25 UTC